Keyphrases
Retrospective Cohort Study
100%
Advanced Melanoma
100%
Timing of Therapy
100%
Systemic Therapy
100%
Netherlands
14%
Number of Patients
14%
Comorbidity
14%
High Cost
14%
Patient Characteristics
14%
Female Sex
14%
Potential Gains
14%
Shared Decision Making
14%
Immune Therapy
14%
Tumor Characteristics
14%
Cancer Registry
14%
New Therapies
14%
BRAF mutation
14%
Comorbidity Index
14%
Elevated LDH
14%
Poor Performance Status
14%
ECOG Performance Status
14%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Melanoma
100%
Comorbidity
66%
Side Effect
33%
Neoplasm
33%
Immunotherapy
33%
Cancer Registry
33%
Lactate Dehydrogenase
33%
Medicine and Dentistry
Nodular Melanoma
100%
Retrospective Cohort Study
100%
Systemic Therapy
100%
Immunotherapy
14%
Health Care Cost
14%
Side Effect
14%
Neoplasm
14%
Shared Decision Making
14%
Cancer Registry
14%
Lactate Dehydrogenase
14%
Electrocorticography
14%
Immunology and Microbiology
Comorbidity
100%
Immunotherapy
50%
Shared Decision Making
50%